Axe Compute Inc (AGPU)
Axe Compute Inc. is a Nasdaq-listed common stock issuer based in Pittsburgh, Pennsylvania. The company, incorporated in 2002, operates as a healthcare technology and equipment business with two reported segments: Pittsburgh and Eagan. In its Pittsburgh segment, Axe Compute applies artificial intelligence to support cancer therapy discovery and development, using a proprietary biobank of more than 150,000 tumor samples and developing 3D culture models for drug research. Its Eagan segment manufactures the FDA-cleared STREAMWAY System and related products for automated medical fluid waste management and patient-to-drain disposal. The company was formerly known as Predictive Oncology Inc. and adopted the Axe Compute Inc. name in December 2025. It also has a strategic collaboration with Every Cure focused on identifying and prioritizing drugs for repurposing.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AGPU
|
$10.77
|
-13.7% Downside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 12, 2026
|
4.3x
|
44.4x
|
144.8 M
|
124.5 M
|
1.1%
|
96.9%
|
-6.2
|
2.2%
|
